1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International J of Cancer. 127(12):2893–2917. 2010.
Article
2. Weber DC, Trofimov AV, Delaney TF, Bortfeld T. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. Int J Radiat Oncol Biol Phys. 58(5):1596–1606. 2004.
Article
3. Chung JB, Kim TS, Kim IA, Lee JW, Cho W, Suh TS. The effect of photon energy on the intensity-modulated radiation therapy plan for prostate cancer: a planning study. Korean Phys Soc. 59(1):183–188. 2011.
Article
4. Trofimov A, Nguyen PL, Coen JJ, et al. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison. Int J Radiat Oncol Biol Phys. 69(2):444–453. 2007.
Article
5. Goitein M, Lomax AJ, Pedroni ES. Treating cancer with protons. Physics Today. 55(9):45–50. 2002.
Article
6. Jones B, Burnet N. Radiotherapy for the future - Protons and ions hold much promise. British Medical J. 330(7498):979–980B. 2005.
7. Goitein M, Lomax AJ, Pedroni ES. Weighing proton therapy's clinical readiness and costs. Physics Today. 56(6):13–14. 2003.
Article
8. Kase Y, Yamashita H, Fuji H, et al. A treatment planning comparison of passive-scattering and intensity-modulated proton therapy for typical tumor sites. J of Radiation Research. 2011.
9. Nutting CM, Convery DJ, Cosgrove VP, et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 48(3):649–656. 2000.
Article
10. Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol. 44(1):185–205. 1999.
Article
11. Oelfke U, Bortfeld T. Inverse planning for photon and proton beams. Med Dos. 26(2):113–124. 2001.
Article
12. Cella L, Lomax A, Miralbell R. Potential role of intensity modulated proton beams in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys. 49(1):217–223. 2001.
Article
13. Steneker M, Lomax A, Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiat Oncol. 80(2):263–267. 2006.
Article
14. Huchet A, Caudry M, Belkacemi Y, et al. Volume-effect and radiotherapy [II]. Part II: volume-effect and normal tissue. Cancer Radiotherapie. 7(5):353–362. 2003.
15. Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys. 46(3):619–630. 2000.
Article
16. Dearnaley DP, Hall E, Lawrence D, et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. British J of Cancer. 92(3):488–498. 2005.
Article
17. Peeters ST, Heemsbergen WD, Koper PC, et al. Doseresponse in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J of Clinical Oncology. 24(13):1990–1996. 2006.
Article
18. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 53(5):1097–1105. 2002.
Article
19. Michalski JM, Winter K, Purdy JA, et al. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Int J Radiat Oncol Biol Phys. 62(3):706–713. 2005.
Article
20. Rossi CJ Jr, Slater JD, Yonemoto LT, et al. Influence of patient age on biochemical freedom from disease in patients undergoing conformal proton radiotherapy of organ-confined prostate cancer. Urology. 64(4):729–732. 2004.
Article
21. Vargas C, Fryer A, Mahajan C, et al. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 70(3):744–751. 2008.
Article